Drug Safety Alerts

S2 Racepinephrine Inhalation Solution, 2.25% Unit Dose Patient-Level Recall

1/20/2023

On January 20, 2023, Nephron Pharmaceuticals Corporation issued a recall of S2 Racepinephrine Inhalation Solution, 2.25% Unit Dose. According to Nephron, this recall was issued out of an abundance of caution due to the potential for low fill volume.

This could be a health hazard or safety risk to patients who may be using product affected by this recall.

A complete list of affected products and lot numbers can be foundhere.

CVS Caremark Response: Please note that this product is not carried at CVS Caremark Mail Service Pharmacies.

For more information about this recall, please call Nephron Pharmaceuticals Corporation at 1-844-341-5200, Monday through Friday, 8:00 AM – 8:00 PM (EST) or email recall@nephronpharm.com. You may also call the U.S. Food and Drug Administration (FDA) consumer inquiry line at 1-888-INFO-FDA (1-888-463-6332) or visit www.fda.gov.